These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21896621)

  • 41. Thyroid Hormone Transporters.
    Groeneweg S; van Geest FS; Peeters RP; Heuer H; Visser WE
    Endocr Rev; 2020 Apr; 41(2):. PubMed ID: 31754699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thyroid hormone transporters--functions and clinical implications.
    Bernal J; Guadaño-Ferraz A; Morte B
    Nat Rev Endocrinol; 2015 Jul; 11(7):406-17. PubMed ID: 25942657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency.
    Kersseboom S; Horn S; Visser WE; Chen J; Friesema EC; Vaurs-Barrière C; Peeters RP; Heuer H; Visser TJ
    Mol Endocrinol; 2014 Dec; 28(12):1961-70. PubMed ID: 25389909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expanding the phenotypic spectrum of Allan-Herndon-Dudley syndrome in patients with SLC16A2 mutations.
    Remerand G; Boespflug-Tanguy O; Tonduti D; Touraine R; Rodriguez D; Curie A; Perreton N; Des Portes V; Sarret C;
    Dev Med Child Neurol; 2019 Dec; 61(12):1439-1447. PubMed ID: 31410843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired T3 uptake and action in MCT8-deficient cerebral organoids underlie Allan-Herndon-Dudley syndrome.
    Salas-Lucia F; Escamilla S; Bianco AC; Dumitrescu A; Refetoff S
    JCI Insight; 2024 Feb; 9(7):. PubMed ID: 38376950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis.
    Mayerl S; Müller J; Bauer R; Richert S; Kassmann CM; Darras VM; Buder K; Boelen A; Visser TJ; Heuer H
    J Clin Invest; 2014 May; 124(5):1987-99. PubMed ID: 24691440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development.
    van Geest FS; Gunhanlar N; Groeneweg S; Visser WE
    Front Endocrinol (Lausanne); 2021; 12():723750. PubMed ID: 34539576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel variant in SLC16A2 associated with typical Allan-Herndon-Dudley syndrome: a case report.
    Chen X; Liu L; Zeng C
    BMC Pediatr; 2022 Apr; 22(1):180. PubMed ID: 35382784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Zebrafish as a model for monocarboxyl transporter 8-deficiency.
    Vatine GD; Zada D; Lerer-Goldshtein T; Tovin A; Malkinson G; Yaniv K; Appelbaum L
    J Biol Chem; 2013 Jan; 288(1):169-80. PubMed ID: 23161551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allan-Herndon-Dudley syndrome.
    Verma S
    Indian J Pediatr; 2008 Apr; 75(4):402-4. PubMed ID: 18589880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A family with Allan-Herndon-Dudley syndrome due to SLC16A2 gene mutation].
    Tang YL; Peng J; Xiong J; Pang N; Wu LW; Yang HY; Kessi M; Yin F
    Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):829-834. PubMed ID: 30392207
    [No Abstract]   [Full Text] [Related]  

  • 52. First female with Allan-Herndon-Dudley syndrome and partial deletion of X-inactivation center.
    Quesada-Espinosa JF; Garzón-Lorenzo L; Lezana-Rosales JM; Gómez-Rodríguez MJ; Sánchez-Calvin MT; Palma-Milla C; Gómez-Manjón I; Hidalgo-Mayoral I; Pérez de la Fuente R; Arteche-López A; Álvarez-Mora MI; Camacho-Salas A; Cruz-Rojo J; Lázaro-Rodríguez I; Morales-Conejo M; Nuñez-Enamorado N; Bustamante-Aragones A; Simón de Las Heras R; Gomez-Cano MA; Ramos-Gómez P; Sierra-Tomillo O; Juárez-Rufián A; Gallego-Merlo J; Rausell-Sánchez L; Moreno-García M; Sánchez Del Pozo J
    Neurogenetics; 2021 Oct; 22(4):343-346. PubMed ID: 34296368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Exome sequencing revealed Allan-Herndon-Dudley syndrome underlying multiple disabilities].
    Arvio M; Philips AK; Ahvenainen M; Somer M; Kalscheuer V; Järvelä I
    Duodecim; 2014; 130(21):2202-5. PubMed ID: 25582014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of Mct8/Oatp1c1 dKO mice as a model organism for the Allan-Herndon-Dudley Syndrome.
    Maity-Kumar G; Ständer L; DeAngelis M; Lee S; Molenaar A; Becker L; Garrett L; Amerie OV; Hoelter SM; Wurst W; Fuchs H; Feuchtinger A; Gailus-Durner V; Garcia-Caceres C; Othman AE; Brockmann C; Schöffling VI; Beiser K; Krude H; Mroz PA; Hofmann S; Tuckermann J; DiMarchi RD; Hrabe de Angelis M; Tschöp MH; Pfluger PT; Müller TD
    Mol Metab; 2022 Dec; 66():101616. PubMed ID: 36270613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allan-Herndon-Dudley-Syndrome: Considerations about the Brain Phenotype with Implications for Treatment Strategies.
    Krude H; Biebermann H; Schuelke M; Müller TD; Tschöp M
    Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):414-422. PubMed ID: 32242326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?
    Vancamp P; Demeneix BA; Remaud S
    Front Endocrinol (Lausanne); 2020; 11():283. PubMed ID: 32477268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modeling the Biochemical Phenotype of MCT8 Mutations In Vitro: Resolving a Troubling Inconsistency.
    Braun D; Reuter U; Schweizer U
    Endocrinology; 2019 Jun; 160(6):1536-1546. PubMed ID: 31127274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AAV9-MCT8 Delivery at Juvenile Stage Ameliorates Neurological and Behavioral Deficits in a Mouse Model of MCT8-Deficiency.
    Liao XH; Avalos P; Shelest O; Ofan R; Shilo M; Bresee C; Likhite S; Vit JP; Heuer H; Kaspar B; Meyer K; Dumitrescu AM; Refetoff S; Svendsen CN; Vatine GD
    Thyroid; 2022 Jul; 32(7):849-859. PubMed ID: 35350867
    [No Abstract]   [Full Text] [Related]  

  • 59. Movement Disorder Perspectives on Monocarboxylate 8 Deficiency: A Case Series of 3 Colombian Patients with Allan-Herndon-Dudley Syndrome.
    Ramon-Gomez JL; Cortés-Rojas MC; Polania-Puentes MJ; Guerrero-Ruiz GDP
    Mov Disord Clin Pract; 2024 May; 11(5):567-570. PubMed ID: 38454300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MCT8 deficiency in Purkinje cells disrupts embryonic chicken cerebellar development.
    Delbaere J; Vancamp P; Van Herck SL; Bourgeois NM; Green MJ; Wingate RJ; Darras VM
    J Endocrinol; 2017 Feb; 232(2):259-272. PubMed ID: 27879339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.